The FDA lists BPC-157 among bulk drug substances used in compounding that present significant safety risks, which limits routine compounding and prescription access in the United States
Men and women may yield different consequences based on dose, route, and biology
We review your symptoms, health history, recovery goals, and treatment options before recommending any protocol including whether BPC-157 capsules or injections are appropriate for your situation
Simple oral capsule format eliminates injection requirements, improves compliance, allows for convenient daily dosing, and provides easier integration into existing supplement routines
Dihexa, a potent neuropeptide analog derived from angiotensin IV (AngIV), has garnered significant attention in neuroscience research for its remarkable neurogenic and synaptogenic properties